Re:Opaque drug pricing in the U.S.
by Animats on Sunday March 12, 2017 @06:18PM
(#13853480)
"Detail", in pharma parlance, refers to making sales presentations to physicians. The people who do this were once called "detail men".[1] This has declined somewhat now that pharma can advertise prescription drugs directly to patients.
[1] https://www.theatlantic.com/magazine/archive/2006/04/the-dru...